Ericka Robinson: Welcoming Vishakha K. Kumar to ISTH
Ericka Robinson, Director of People, Culture and Talent at International Society on Thrombosis and Haemostasis (ISTH), shared a post on LinkedIn:
“Exciting ISTH news to share!
I am beyond excited and delighted to share that we are officially welcoming Vishakha K. Kumar, M.D., MBA, as the new Executive Director/CEO of the International Society on Thrombosis and Haemostasis (ISTH)!
It has truly been a privilege to witness the dedication and thoughtfulness that went into selecting the right leader for this important role.
Vishakha brings a wealth of experience, strategic vision, and a genuine passion for advancing our mission and serving the global thrombosis and hemostasis community.
Congratulations, Vishakha!
We are excited for all that lies ahead and look forward to the impact you’ll make as we continue to advance ISTH’s mission together!
Learn more about Vishakha and read the official ISTH announcement.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 11:21Thrombotic Microangiopathies: From Clinical Syndrome to Molecularly Targeted Therapy
-
Sep 3, 2026, 10:56Elias Othman: Can an Enzyme Involved in Cell Signaling Become a Target for Antithrombotic Drug Discovery?
-
Sep 3, 2026, 10:42Jared Griffard: Hemorrhagic Shock and Component Blood Transfusion
-
Sep 3, 2026, 10:31Alan Nurden: Comparing Antiplatelet and Antithrombin Therapies in Coronary Microcirculation
-
Sep 3, 2026, 08:53Jamie’s Journey Through a Decade with Immune Thrombocytopenia – ITP Support Association
-
Sep 3, 2026, 08:00Beth Meneley: When Transfusion Is Not an Option – HBOT for Exceptional Blood Loss Anemia
-
Sep 3, 2026, 06:27Seyed Mehrab Safdari: Unmasking Factor VII Padua to Prevent Unnecessary Therapy and Thrombotic Risk
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease